Written By Lexx Thornton The first aceclidine- based eye drop to improve near vision in adults with presbyopia, which affects more than 100 million adults in the US alone, has been approved by the Food and Drug Administration (FDA) and will be available within three months. Known as VIZZ, from pharmaceutical company LENZ, the drops
More
By Gloria Oladipo As Labor Day rallies took place across the US, the Chicago mayor Brandon Johnson sharply denounced the Trump administration’s threat to deploy federal troops to the city as part of an immigration crackdown. “No federal troops in the city of Chicago,” said Johnson on Monday to a gathered crowd at the “Workers over Billionaires”
More
By Rohan Nadkarni On June 6, a long-awaited, landmark moment finally arrived for college athletes: For the first time in the history of the NCAA, schools were given the right to directly pay players. As a result of a lawsuit filed against the NCAA in 2020, a settlement approved by U.S. District Judge Claudia Wilken allowed
More
A government shutdown deadline, a standoff over President Donald Trump’s nominees and a renewed clash over the Jeffrey Epstein files await Congress as it returns Tuesday after a month-long August recess. The top item on the agenda is the government funding deadline of Sept. 30 to avoid a shutdown. An unusual Republican and Democratic pairing says they believe
More
By Doha Madani President Donald Trump demanded that pharmaceutical companies release data pertaining to the success rates of their Covid “drugs” in order to clear up the what he called a discrepancy “mess” over the products, though some information already appears to be available. In a Truth Social post on Monday, Trump wrote that he’s seen “extraordinary” information
More
